Yüklüyor......
Gene expression assay and Watson for Oncology for optimization of treatment in ER-positive, HER2-negative breast cancer
BACKGROUND: Personalized treatment for cancer patients is a hot topic of debate, particularly the decision to initiate chemotherapy in patients with Estrogen receptor (ER)-positive, HER2-negative tumors in the early stages of breast cancer (BC). Owing to significant advancements in information techn...
Kaydedildi:
| Yayımlandı: | PLoS One |
|---|---|
| Asıl Yazarlar: | , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
Public Library of Science
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6034851/ https://ncbi.nlm.nih.gov/pubmed/29979736 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0200100 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|